DANAHER CORPORATION (DHR)
Healthcare › Industrial Instruments For Measurement, Display, and Control
Price History
Feb 9, 2026 — Apr 4, 2026Investment Snapshot
- Trading 119% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 5/9 — moderate financial health
- ROE of 6.2% — below-average profitability
DANAHER CORPORATION (DHR) is a Healthcare company operating in Industrial Instruments For Measurement, Display, and Control, listed on the NYSE , with a market capitalisation of $135.3 billion . Key value metrics: P/E ratio 41.8, P/B ratio 2.58, Piotroski F-Score 5 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
DANAHER CORPORATION — Fundamental Analysis Summary
DANAHER CORPORATION (DHR) is currently trading 119% above its Graham Number of $87.45, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 41.8x.
On financial health, DHR shows a moderate Piotroski F-Score of 5/9, and modest return on equity of 6.2% (sector average: -19.8%), and manageable leverage with a debt-to-equity ratio of 0.35.
StockPik's composite Value Score for DHR is 60/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
DHR reports a solid gross margin of 59.3% (sector average: 33.5%) and a solid operating margin of 17.6%.
DHR shows revenue growing at 3% year-over-year, with earnings declining at 7%.